CMS Proposes Covering Weight-Loss Drugs To Treat Chronic Condition

The Biden administration is proposing a midnight rule to cover anti-obesity medications as a chronic disease treatment under Medicare and Medicaid, and says the Inflation Reduction Act’s drug price negotiation program would lower the drugs’ prices when the new rule kicks in. “The proposed rule would be implemented at the same time as a comprehensive agenda to lower the costs of drugs, including the drug price negotiation program and increased market competition. We can lower drug prices and improve health...